Skip to search formSkip to main contentSkip to account menu

chylomicron remnant clearance

The process in which a chylomicron remnant is removed from the blood via receptor-mediated endocytosis into liver cells and its constituent parts… 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

apolipoprotein E recycling

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
An Apolipoprotein(a) Peptide Delays Chylomicron Remnant Clearance and Increases Plasma Remnant Lipoproteins and Atherosclerosis In Vivo
Objective—Humans with high expression of apolipoprotein(a) [apo(a)] and high plasma levels of lipoprotein(a) [Lp(a)] are at… 
2005
2005
Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients…
2004
2004
W01.90 Effects of expanded dose simvastatin on fasting lipoprotein profile and postprandial chylomicron remnant clearance in normolipidemic patients with premature coronary sclerosis
2000
2000
Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease.
1998
1998
Normal postprandial lipemia and chylomicron clearance in offspring of parents with early coronary artery disease.
To assess the importance of postprandial lipemia and delayed chylomicron clearance as early atherogenic risk factors, 60 male… 
1994
1994
Dissection of the chylomicron remnant clearance pathway
Highly Cited
1992
Highly Cited
1992
Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans.
To characterize chylomicron remnant clearance by the liver, plasma elimination of retinyl palmitate-labeled chylomicron remnants… 
1992
1992
Determinants of fasting plasma triglyceride levels: metabolism of hepatic and intestinal lipoproteins
Abstract. The contribution of the kinetics of exogen‐eous and endogenous lipoproteins in determining the level of triglyceride in… 
1990
1990
Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor.
1984
1984
DEFECTIVE CHYLOMICRON REMNANT CLEARANCE IN PATIENTS WITH FAMILIAL DYSBETAL IPOPROTEINEMIA
Familial dysbetalipoproteinemia results in part from a genetic defect in apolipoprotein E (apoE) which prevents normal binding of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)